CA Turner, SM Clinton… - Proceedings of the …, 2011 - National Acad Sciences Individuals with mood disorders exhibit alterations in the fibroblast growth factor system, including reduced hippocampal fibroblast growth factor-2 (FGF2). It is difficult, however, to pinpoint whether these alterations are a cause or consequence of the disorder. The present study asks ... Cited by 1 - Related articles - All 3 versions
EN Taylor, EB Rimm, MJ Stampfer… - American Heart Journal, 2011 - Elsevier Mean estimated glomerular filtration rate was 86 mL/min per 1.73 m 2 in cases and controls. At baseline, there were no statistically significant differences between cases and controls in plasma levels of FGF23, PTH, or phosphorus. After adjusting for matching factors, family history of ... Cited by 1 - Related articles - All 7 versions
A Martin, S Liu, V David, H Li, A Karydis… - The FASEB Journal, 2011 - FASEB ABSTRACT Fibroblastic growth factor 23 (FGF23) is a circulating phosphaturic hormone. Inactivating mutations of the endopeptidase PHEX or the SIBLING protein DMP1 result in equivalent intrinsic bone mineralization defects and increased Fgf23 expression in osteocytes. The ... Cited by 1 - Related articles - All 2 versions
K Hosono, T Suzuki, H Tamaki… - … , and vascular biology, 2011 - Am Heart Assoc Methods and Results— Lymphangiogenesis estimated by podoplanin/vascular endothelial growth factor (VEGF) receptor-3/LYVE-1 expression was upregulated during proliferative inflammation seen around and into subcutaneous Matrigel plugs containing fibroblast growth factor-2 ( ... Related articles - All 5 versions
T Isakova, OM Gutiérrez, K Smith… - Nephrology Dialysis …, 2011 - ERA-EDTA Results. Compared with the 1500-mg phosphorus diet, patients assigned to the 750-mg diet had greater reduction in 24-h urinary phosphate excretion (66% vs. 29%; P < 0.0001). Lanthanum-treated patients experienced a significant reduction in 24-h urinary ... Cited by 11 - Related articles - All 6 versions